Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 3347Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
Kathryn J. Hammer,Vanessa C. Copeland,Elizabeth T. Loggers,Seth M. Pollack,Michael J. Wagner,Lee D. Cranmer
American Journal of Clinical Oncology.2020;43(6)446
[DOI]
2Compassionate drug use: Current status in India
YashashriC Shetty,Smita Brahma,PS Manjesh
Perspectives in Clinical Research.2020;11(1)3
[DOI]
3Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations
PardeepKumar Goyal,Roli Mathur,Bikash Medhi
Indian Journal of Pharmacology.2020;52(3)163
[DOI]
4Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
Camille Taillé,Pascal Chanez,Gilles Devouassoux,Alain Didier,Christophe Pison,Gilles Garcia,Jeremy Charriot,Stéphane Bouée,Alina Gruber,Celine Pribil,Arnaud Bourdin,Marc Humbert
European Respiratory Journal.2020;55(6)1902345
[DOI]
5What do patients with unmet medical needs want? A qualitative study of patients’ views and experiences with expanded access to unapproved, investigational treatments in the Netherlands
Eline M. Bunnik,Nikkie Aarts
BMC Medical Ethics.2019;20(1)1902345
[DOI]
6An overview of Compassionate Use Programs in the European Union member states
Gayathri Balasubramanian,Suman Morampudi,Pankdeep Chhabra,Arun Gowda,Behsad Zomorodi
Intractable & Rare Diseases Research.2016;5(4)244
[DOI]
7Expanding Patient Access to Investigational New Drugs
Gail A. Van Norman
JACC: Basic to Translational Science.2018;3(3)403
[DOI]
8Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing
Aaron S. Mansfield,Ben Ho Park,Michael P. Mullane
American Society of Clinical Oncology Educational Book.2018;3(38)873
[DOI]
9Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology
Olga Löblová,Marcell Csanádi,Piotr Ozieranski,Zoltán Kaló,Lawrence King,Martin McKee
Health Policy.2019;123(7)630
[DOI]
10Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Ajai Chari,Sagar Lonial,Tomer M. Mark,Amrita Y. Krishnan,Keith E. Stockerl-Goldstein,Saad Z. Usmani,Anil Londhe,Delores Etheredge,Sarah Fleming,Baolian Liu,Jon Ukropec,Thomas S. Lin,Sundar Jagannath,Ajay K. Nooka
Cancer.2018;124(22)4342
[DOI]
11Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Louise E. Curley,Maree Jensen,Zaheer-Ud-Din Babar,Sanya Ram
Cancer.2018;124(22)183
[DOI]
12Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016
Olga Löblová,Marcell Csanádi,Piotr Ozieranski,Zoltán Kaló,Lawrence King,Martin McKee
Health Policy.2019;123(8)713
[DOI]
13To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma
Peter Martin,Andre Goy,Radhakrishnan Ramchandren,Lucille Ferrante,Anil Londhe,Tracy McGowan,Nancy L Bartlett
Journal of Oncology Pharmacy Practice.2019;25(4)1027
[DOI]
14Physician perspectives on compassionate use in pediatric oncology
Scott Moerdler,Lindy Zhang,Elena Gerasimov,Chong Zhu,Tamar Wolinsky,Michael Roth,Nancy Goodman,Daniel A. Weiser
Pediatric Blood & Cancer.2019;66(3)e27545
[DOI]
15Physician perspectives on compassionate use in pediatric oncology
Briana Hagelgans
Pediatric Blood & Cancer.2020;66(3)33
[DOI]
16A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
Beatrice Borelli,Gemma Zucchelli,Daniele Rossini,Chiara Cremolini,Carlotta Antoniotti,Roberto Moretto,Federica Marmorino,Camilla Colombo,Francesca Vannini,Laura Delliponti,Mario Spione,Elena Ongaro,Gianluca Masi,Isa Maura Brunetti,Elisabetta Pfanner,Lisa Salvatore,Alfredo Falcone
Colorectal Cancer.2018;7(1)CRC01
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal